Sign Up to Receive Your Personalised Learning Resources
touchEXPERT OPINIONS
The mRNA vaccine platform: A novel tool for the rapid development of vaccines against respiratory viral infections
Start Learning
P2X3 receptor antagonists for the treatment of chronic cough: Imran Satia, ERS 2023
An Algorithm for the Identification and Management of Chronic Rhinosinusitis: The European Forum for Research and Education in Allergy and Airway Diseases Pocket Guide
Emerging second-line treatment approaches in advanced NSCLC: The role of ADCs
Expert insights in food allergy: Considerations for diagnosis and management in primary care and beyond
Physiological benefits of pulmonary rehabilitation prior to lung transplantation: David R. Nunley, ATS 2023
A subgroup analysis of the WILLOW study – brensocatib in bronchiectasis by disease severity: Mark Metersky, ATS 2023
Cytisinicline for Smoking Cessation in Adult Smokers
Overcoming challenges in advanced or metastatic squamous cell lung cancer: Focus on immunotherapy
Gefapixant for the treatment of chronic cough – a dose-response analysis: Elena Kum, ERS 2023
Alvelestat: An Investigational Oral Neutrophil Elastase Inhibitor for the Treatment of Alpha-1 Antitrypsin Deficiency-associated Emphysema
Sign up to view Favourites, Keep Notes and Track CME Credits
Favourites
CLEAN-PCD: a phase 2 study of idrevloride in primary ciliary dyskinesia: Thomas Ferkol, ERS 2023
View
Non-invasive Ventilation to Provide a More Positive Outlook in Neuromuscular Disease: An Update on the CHEST Guidelines
View
Ronald Strauss, AAAAI 2023: Hot topics to explore in the field of respiratory medicine
View
Dupilumab: an investigational monoclonal antibody for COPD: Klaus F. Rabe, ATS 2023
View
Alvelestat: An Investigational Oral Neutrophil Elastase Inhibitor for the Treatment of Alpha-1 Antitrypsin Deficiency-associated Emphysema
View
An Algorithm for the Identification and Management of Chronic Rhinosinusitis: The European Forum for Research and Education in Allergy and Airway Diseases Pocket Guide
View
Acetazolamide to prevent altitude-related adverse health effects in COPD: Michael Furian, ERS 2023
View
Camlipixant: A New Treatment Option for Refractory Chronic Cough?
View
The Effect of Lebrikizumab on Inflammatory Biomarkers in Patients with Asthma
View
BOREAS: phase 3 study of dupilumab in COPD: Klaus F. Rabe, ATS 2023
View